Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Abhijit Chakraborty,Atul Katarkar,Keya Chaudhuri,Ashis Mukhopadhyay,Jayasri Basak

DOI: https://doi.org/10.2478/s11658-014-0184-6

2014-03-15

Abstract:[This corrects the article DOI: 10.2478/s11658-013-0110-3.].

What problem does this paper attempt to address?

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Xiang P. Liu,Li J. Gao,Ben T. She,Gui X. Li,Yun R. Wu,Ji M. Xu,Zhong J. Ding,Jian F. Ma,Shao J. Zheng

DOI: https://doi.org/10.1111/pce.14419

2022-01-01

Abstract:In the published article, the author names in the byline which originally appeared as “Xiang P. Liu, Li J. Gao, Ben T. She, Gui X. Li, Yun R. Wu, Ji M. Xu, Zhong J. Ding, Jian F. Ma, Shao J. Zheng” have been corrected to “Xiangpei Liu, Lijun Gao, Bentao She, Guixin Li, Yunrong Wu, Jiming Xu, Zhongjie Ding, Jianfeng Ma, Shaojian Zheng” in the byline and the ORCID ID section. We apologize for this error.
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Bin Ma,Wenjia Guo,Meihui Shan,Nan Zhang,Binlin Ma,Gang Sun

DOI: https://doi.org/10.1515/biol-2022-0810

2023-12-16

Abstract:[This corrects the article DOI: 10.1515/biol-2020-0054.].
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Liu, Bei,Chen, Song-Chang,Yang, Yan-Mei,Yan, Kai,Qian, Ye-Qing,Zhang, Jun-Yu,Hu, Yu-Ting,Dong, Min-Yue,Jin, Fan,Huang, He-Feng,Xu, Chen-Ming

DOI: https://doi.org/10.1038/srep21578

IF: 4.6

2016-01-01

Scientific Reports

Abstract:Scientific Reports 5: Article number: 17468; published online: 03 December 2015; updated: 23 February 2016 This Article contains typographical errors in Table 2. For Family No. 19, the cDNA change ‘c.8795_8796insA’ and protein change ‘p.His2932GlnfsX5’ were incorrectly given as ‘c.8495-8496insA’ and‘p.
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Hae Sang Park,Shinya Yokomizo,Haoran Wang,Sophia Manganiello,Hailey Monaco,Rose McDonnell,Hajin Joanne Kim,Jiyun Rho,Sung Ahn,Jason Gladstone,Harry Jung,Homan Kang,Kai Bao,Satoshi Kashiwagi,Hak Soo Choi

DOI: https://doi.org/10.34133/bmr.0036

2024-05-29

Abstract:[This corrects the article DOI: 10.34133/bmr.0002.].
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Bryan E Welm,Christos Vaklavas,Alana L Welm

DOI: https://doi.org/10.1063/5.0057199

2021-06-02

Abstract:[This corrects the article DOI: 10.1063/5.0030534.].
Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Yutong Wang,Mengzhen Wang,Bin Chu,Minqiu Lu,Lei Shi,Shan Gao,Yuan Chen,Qin Yan,Na Ji,Li Bao

DOI: https://doi.org/10.1016/j.cpt.2024.09.002

2024-09-14

Abstract:[This corrects the article DOI: 10.1016/j.cpt.2023.12.004.].
Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Mostafa Heidari Majd,Xiangyu Guo

DOI: https://doi.org/10.2174/187152062405240209150030

IF: 2.8

2024-02-01

Anti-Cancer Agents in Medicinal Chemistry

Abstract:A typographical error appeared in the author affiliation titled “Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells”, published in Anti-Cancer Agents in Medicinal Chemistry, 2023, 23(15) [1]. Details of the error and a correction are provided here. Original: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital Chinese Academy of Medical Science, Liaoning Provincial Cancer Hospital, Shenyang, Liaoning, 110042, China Corrected: Author Affiliation: 2Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, China We regret the error and apologize to readers. The original article can be found online at https://www.eurekaselect.com/article/131718

oncology,chemistry, medicinal
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Correction: Corrigendum: Protein-structure-guided Discovery of Functional Mutations Across 19 Cancer Types

Beifang Niu,Adam D Scott,Sohini Sengupta,Matthew H Bailey,Prag Batra,Jie Ning,Matthew A Wyczalkowski,Wen-Wei Liang,Qunyuan Zhang,Michael D McLellan,Sam Q Sun,Piyush Tripathi,Carolyn Lou,Kai Ye,R Jay Mashl,John Wallis,Michael C Wendl,Feng Chen,Li Ding

DOI: https://doi.org/10.1038/ng0817-1286a

IF: 30.8

2017-01-01

Nature Genetics

Abstract:Nat. Genet. 48, 827–837 (2016); published online 13 June 2016; corrected after print 20 March 2017 In the version of this article initially published, residue R384 was incorrectly highlighted in the protein model depicted in Figure 7e. The correct residue is R394. The error has been corrected in theHTML and PDF versions of the article.
Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Uttpal Anand,Abhijit Dey,Arvind K Singh Chandel,Rupa Sanyal,Amarnath Mishra,Devendra Kumar Pandey,Valentina De Falco,Arun Upadhyay,Ramesh Kandimalla,Anupama Chaudhary,Jaspreet Kaur Dhanjal,Saikat Dewanjee,Jayalakshmi Vallamkondu,José M Pérez de la Lastra,Arvind K. Singh Chandel,José M. Pérez de la Lastra

DOI: https://doi.org/10.1016/j.gendis.2024.101211

IF: 7.376

2024-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.007.].

genetics & heredity,biochemistry & molecular biology
Erratum to "Not so Rare: Diseases based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering"

DOI: https://doi.org/10.1177/25152564241276081

2024-09-24

Abstract:[This corrects the article DOI: 10.1177/25152564241261228.].
Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Blanche P. Alter,Ana F. Best

DOI: https://doi.org/10.1007/s10549-020-05775-3

2020-07-08

Breast Cancer Research and Treatment

Abstract:In the original publication of the article, the first sentence in the abstract was published incorrectly.

oncology
Errors in Key Points and Abstract

DOI: https://doi.org/10.1001/jamaoncol.2024.0267

IF: 33.006

2024-03-23

JAMA Oncology

Abstract:In the Original Investigation titled "Investigation of Genetic Alterations Associated With Interval Breast Cancer," 1 published online January 25, 2024, there were errors in the Key Points and In the Key Points, "health controls" now correctly reads "healthy controls." In the , the phrase "and associated with BRCA1/2 and PALB2 variants" is now the sentence "This association was primarily influenced by BRCA1/2 and PALB2 variants." This article was corrected online.

oncology
Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]

Pengzhao Shang,Rui Gao,Yijia Zhu,Xiaorui Zhang,Yang Wang,Minji Guo,Hui Peng,Min Wang,Juan Zhang

DOI: https://doi.org/10.1016/j.apsb.2024.02.014

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2020.09.008.].

Erratum to: Detection of a novel mutation in exon 20 of the BRCA1 gene

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Correction: Corrigendum: Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Erratum: "Toward improved models of human cancer" [APL Bioeng. 5, 010901 (2021)]

Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Corrigendum to: Investigation of the Apoptosis Inducing and β-catenin Silencing by Tetradentate Schiff Base Zinc(II) Complex on the T-47D Breast Cancer Cells

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Correction: Corrigendum: Protein-structure-guided Discovery of Functional Mutations Across 19 Cancer Types

Corrigendum to ‘Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics’ [Genes & Diseases10 (2023) 1367–1401]

Erratum to "Not so Rare: Diseases based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering"

Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

Errors in Key Points and Abstract

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433]